Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04104256 · ClinicalTrials.gov registry record · NA
Using Behavioral Economics to Reduce Low-Value Care
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 1,045
- Enrollment target
NCT04104256: Completed NA study, sponsored by University of California, Los Angeles.
NCT04104256 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 1,045 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (26% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04104256, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,045 participants
- Enrollment target
Study Summary
There is strong consensus - based on robust randomized trial data - that routine pre-operative (pre-op) testing for cataract surgery is inappropriate. Despite these widely endorsed evidence-based recommendations, most seniors undergoing cataract surgery still receive unnecessary blood testing, EKGs, and chest X-rays (CXRs); another substantial percentage even undergo nonindicated cardiac stress tests. We will integrate three new best practice alert (BPA) nudges into the University of California, Los Angeles (UCLA) Health electronic health record (EHR). The nudges are informed by behavioral economic theory and are designed to alter the choice architecture for physicians to decrease the rate of pre-op test ordering while still preserving clinician autonomy. We will conduct a pragmatic trial to evaluate whether these BPA nudges reduce low-value pre-op testing for cataract surgery.
Primary Outcome
Change in percentage of patients undergoing pre-operative testing (labs, EKG, CXR)
Interventions
- OTHER Usual Care
- BEHAVIORAL Nudge #1: Alert highlighting the safety/potential harms to patients of undergoing pre-op tests
- BEHAVIORAL Nudge #2: Alert highlighting the financial harms to the patient experiencing pre-op tests
- BEHAVIORAL Nudge #3: Alert highlighting potential psychological harms to the patient of experiencing pre-op tests
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,045 participants |
| Start Date | 2021-06-24 |
| Est. Completion | 2023-08-14 |
| Phase | NA |
What the finished NCT04104256 record still lists
NCT04104256 is an interventional study that assigns participants to a tested intervention. Its 1,045 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (26% lower).
The record links to 0 conditions, and to 4 interventions - of which Usual Care is the first listed.
NCT04104256 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04104256 about?
NCT04104256 is a clinical study titled "Using Behavioral Economics to Reduce Low-Value Care". There is strong consensus - based on robust randomized trial data - that routine pre-operative (pre-op) testing for cataract surgery is inappropriate. Despite these widely endorsed evidence-based recommendations, most seniors undergoing cataract surgery still receive unnecessary blood testing, EKGs,...
What is the current status of trial NCT04104256?
This trial is currently completed. It is a NA study. The enrollment target is 1,045 participants. The study started on 2021-06-24. Estimated completion is 2023-08-14.
What interventions are being tested in trial NCT04104256?
The interventions under investigation include: Usual Care (OTHER), Nudge #1: Alert highlighting the safety/potential harms to patients of undergoing pre-op tests (BEHAVIORAL), Nudge #2: Alert highlighting the financial harms to the patient experiencing pre-op tests (BEHAVIORAL), Nudge #3: Alert highlighting potential psychological harms to the patient of experiencing pre-op tests (BEHAVIORAL).
Who is sponsoring clinical trial NCT04104256?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04104256's enrollment target sits among peer trials
1,045 100th of 2000 higher than 1,901 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06717347 · 1,046 participants · Phase 3
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
- NCT04685616 · 1,042 participants · Phase 3
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
- NCT04505618 · 1,050 participants · NA
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
- NCT04511806 · 1,050 participants
Childhood Cancer Predisposition Study (CCPS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI